Ariel Investments’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.2M Sell
202,271
-2,781
-1% -$389K 0.32% 63
2025
Q4
$25.2M Sell
205,052
-13,726
-6% -$1.67M 0.27% 69
2025
Q3
$24.3M Sell
218,778
-150,083
-41% -$17.1M 0.26% 68
2025
Q2
$40.9M Sell
368,861
-61,563
-14% -$6.55M 0.46% 52
2025
Q1
$48.2M Buy
430,424
+30,630
+8% +$3.16M 0.57% 48
2024
Q4
$36.9M Buy
399,794
+162,746
+69% +$14.7M 0.39% 64
2024
Q3
$19.9M Sell
237,048
-131,363
-36% -$10M 0.2% 82
2024
Q2
$25.3M Sell
368,411
-374,489
-50% -$25M 0.27% 80
2024
Q1
$54.4M Sell
742,900
-6,840
-0.9% -$526K 0.54% 58
2023
Q4
$60.7M Sell
749,740
-174,247
-19% -$13.6M 0.6% 56
2023
Q3
$69.2M Sell
923,987
-215,344
-19% -$16.6M 0.73% 51
2023
Q2
$87.8M Sell
1,139,331
-35,897
-3% -$2.86M 0.83% 47
2023
Q1
$97.5M Sell
1,175,228
-3,522
-0.3% -$292K 0.94% 41
2022
Q4
$101M Sell
1,178,750
-1,495,360
-56% -$118M 1.03% 41
2022
Q3
$165M Sell
2,674,110
-43,298
-2% -$2.73M 1.81% 20
2022
Q2
$168M Buy
2,717,408
+78,492
+3% +$4.86M 1.68% 23
2022
Q1
$157M Buy
2,638,916
+225,340
+9% +$14.4M 1.39% 31
2021
Q4
$175M Sell
2,413,576
-206,320
-8% -$14.2M 1.48% 26
2021
Q3
$183M Buy
2,619,896
+120,097
+5% +$8.44M 1.67% 20
2021
Q2
$172M Sell
2,499,799
-334,544
-12% -$22.3M 1.62% 21
2021
Q1
$183M Sell
2,834,343
-144,611
-5% -$9.32M 1.8% 18
2020
Q4
$174M Buy
2,978,954
+375,241
+14% +$22.6M 1.96% 14
2020
Q3
$165M Buy
2,603,713
+751,198
+41% +$52.1M 2.39% 10
2020
Q2
$143M Sell
1,852,515
-813,720
-31% -$62.4M 2.17% 12
2020
Q1
$199M Buy
2,666,235
+155,417
+6% +$10.7M 3.5% 4
2019
Q4
$163M Buy
2,510,818
+20,292
+0.8% +$1.32M 2.05% 14
2019
Q3
$158M Sell
2,490,526
-2,401
-0.1% -$157K 2.1% 12
2019
Q2
$168M Buy
2,492,927
+40,695
+2% +$2.68M 2.11% 8
2019
Q1
$159M Buy
2,452,232
+48,183
+2% +$3.2M 1.98% 10
2018
Q4
$150M Hold
2,404,049
2.1% 8
2018
Q3
$186M Buy
2,404,049
+74,789
+3% +$5.65M 2.06% 9
2018
Q2
$165M Buy
2,329,260
+159,941
+7% +$11.3M 1.85% 15
2018
Q1
$164M Sell
2,169,319
-67,018
-3% -$5.33M 1.87% 14
2017
Q4
$160M Buy
2,236,337
+66,900
+3% +$5.08M 1.81% 14
2017
Q3
$176M Buy
2,169,437
+78,624
+4% +$6.01M 2.04% 10
2017
Q2
$148M Buy
2,090,813
+290,612
+16% +$19.3M 1.75% 15
2017
Q1
$122M Buy
1,800,201
+216,002
+14% +$15.2M 1.44% 23
2016
Q4
$113M Buy
1,584,199
+51,671
+3% +$3.84M 1.34% 29
2016
Q3
$121M Buy
1,532,528
+89,223
+6% +$7.25M 1.47% 24
2016
Q2
$120M Buy
1,443,305
+82,813
+6% +$7.35M 1.51% 23
2016
Q1
$125M Buy
1,360,492
+46,992
+4% +$4.24M 1.51% 22
2015
Q4
$133M Hold
1,313,500
1.59% 21
2015
Q3
$129M Buy
1,313,500
+207,006
+19% +$23M 1.61% 16
2015
Q2
$130M Buy
1,106,494
+214,849
+24% +$23.5M 1.46% 21
2015
Q1
$87.5M Buy
891,645
+88,842
+11% +$9.02M 0.98% 39
2014
Q4
$75.7M Buy
802,803
+158,907
+25% +$16.4M 0.87% 43
2014
Q3
$68.5M Buy
643,896
+5,162
+0.8% +$505K 0.88% 43
2014
Q2
$53M Buy
638,734
+241,461
+61% +$18.8M 0.65% 53
2014
Q1
$28.2M Buy
397,273
+72,971
+23% +$5.72M 0.34% 70
2013
Q4
$24.4M Buy
324,302
+259,037
+397% +$18M 0.3% 74
2013
Q3
$4.1M Buy
65,265
+53,209
+441% +$3.18M 0.06% 124
2013
Q2
$618K Buy
+12,056
New +$628K 0.01% 130

Other funds holding GILD

Ariel Investments's GILD Position: Q1 2026 in Review

Ariel Investments reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, selling an estimated $389K and leaving 202,271 shares worth $28.2M. The position accounts for 0.32% of the portfolio, ranked #63.

Ariel Investments first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $199M in Q1 2020. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Ariel Investments held 202,271 shares of Gilead Sciences worth $28.2M as of Q1 2026.
  • Ariel Investments sold 2,781 Gilead Sciences shares in Q1 2026, an estimated $389K.
  • Gilead Sciences made up 0.32% of Ariel Investments's portfolio in Q1 2026, its #63 holding.
  • Ariel Investments first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Ariel Investments's Gilead Sciences position peaked at $199M in Q1 2020.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Ariel Investments's 13F filing for Q1 2026, filed 14 May 2026.